What is NervGen Pharma Corp. Common stock's Market Cap?

NervGen Pharma Corp. Common stock's Market Cap is $173.6M, based on as-reported figures from SEC (XBRL) filings.

What is NervGen Pharma Corp. Common stock's Enterprise Value?

NervGen Pharma Corp. Common stock's Enterprise Value is $157.5M, based on as-reported figures from SEC (XBRL) filings.

What is NervGen Pharma Corp. Common stock's Net Income (TTM)?

NervGen Pharma Corp. Common stock's Net Income (TTM) is -$32.2M, based on as-reported figures from SEC (XBRL) filings.

What is NervGen Pharma Corp. Common stock's Diluted EPS (TTM)?

NervGen Pharma Corp. Common stock's Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.

What is NervGen Pharma Corp. Common stock's Net Debt?

NervGen Pharma Corp. Common stock's Net Debt is -$16.1M, based on as-reported figures from SEC (XBRL) filings.

NervGen Pharma Corp. Common stock (NGEN) Financial Statements

NervGen Pharma Corp. Common stock

SIC 3820

FIGI BBG00MMMWGD3

XNAS · usd

2.18▼ 0.01 (-0.46%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.19

Day's Range2.16 – 2.35

52-Week Range1.58 – 6.30

Volume712.9K

Avg Volume528.5K

Share Statistics

Shares Outstanding

Employees9

ExchangeXNAS

Listed2019-03-25

Share count as of December 31, 2025

ViewDetail

Period

Loading Income Statement…

Key questions about NervGen Pharma Corp. Common stock (NGEN)

What is NervGen Pharma Corp. Common stock's Market Cap?: NervGen Pharma Corp. Common stock's Market Cap is $173.6M, based on as-reported figures from SEC (XBRL) filings.
What is NervGen Pharma Corp. Common stock's Enterprise Value?: NervGen Pharma Corp. Common stock's Enterprise Value is $157.5M, based on as-reported figures from SEC (XBRL) filings.
What is NervGen Pharma Corp. Common stock's Net Income (TTM)?: NervGen Pharma Corp. Common stock's Net Income (TTM) is -$32.2M, based on as-reported figures from SEC (XBRL) filings.
What is NervGen Pharma Corp. Common stock's Diluted EPS (TTM)?: NervGen Pharma Corp. Common stock's Diluted EPS (TTM) is -0.40, based on as-reported figures from SEC (XBRL) filings.
What is NervGen Pharma Corp. Common stock's Net Debt?: NervGen Pharma Corp. Common stock's Net Debt is -$16.1M, based on as-reported figures from SEC (XBRL) filings.